Hopax finishes the expansion of its biological buffers manufacturing center in Taiwan
Hopax has just finished the expansion of its manufacturing facilities for biological buffers in Kaohsiung, Taiwan.
The expansion included the addition of new dedicated manufacturing lines for buffers of high demand, such as HEPES, MOPS and Bis-Tris. These lines received new reactors and dryers that will speed up the production and consequently reduce the lead time for Hopax’s pharmaceutical and life sciences customers in Europe, America and Asia.
This move is a logical step in order to meet the growing global demand for these chemicals – as experienced in 2018 – and to maintain Hopax’s position among the world’s largest manufacturers of biological buffers.
Kaohsiung factory expansion will also allow Hopax to maintain larger quantities of buffers available in stock, and therefore improve our capability to develop partnerships with new customers.
Check the full list of Hopax Biological Buffers
YOU MIGHT ALSO LIKE
- News Hopax started the expansion of its production center for additives for Lithium-ion batteries and electroplating 2019.01.15 Hopax has just started the expansion of its manufacturing facilities in Changshu, China. Changshu is Hopax’s production center of additives used in Li-ion battery electrolytes and electroplating...
- Awards Hopax listed among Taiwan’s most sustainable and transparent companies in 2018 2018.11.22 For the second year in a row Hopax is among Taiwan’s most sustainable and transparent companies according to the Taiwan Academy for Corporate Sustainability.